Amid a spate of biopharma CEO pivots, two prominent contract manufacturers from Europe are getting in on the action. Monday, Rentschler revealed its chief executive, Frank Mathias, Ph.D., was stepping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results